Cargando…

Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics

To study host-virus interactions after SARS coronavirus-2 (SARS-CoV-2) infection, genetic virus characteristics and the ensued humoral immune response were investigated for the first time. Fifty-five SARS-CoV-2-infected patients from the early pandemic phase were followed up including serological te...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Jonas, Berghaus, Sandro, Blessing, Frithjof, Wenzel, Folker, Herbeck, Holger, Blessing, Josef, Schierack, Peter, Rödiger, Stefan, Roggenbuck, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408040/
https://www.ncbi.nlm.nih.gov/pubmed/34468954
http://dx.doi.org/10.1007/s11357-021-00443-w
_version_ 1783746742957637632
author Schmidt, Jonas
Berghaus, Sandro
Blessing, Frithjof
Wenzel, Folker
Herbeck, Holger
Blessing, Josef
Schierack, Peter
Rödiger, Stefan
Roggenbuck, Dirk
author_facet Schmidt, Jonas
Berghaus, Sandro
Blessing, Frithjof
Wenzel, Folker
Herbeck, Holger
Blessing, Josef
Schierack, Peter
Rödiger, Stefan
Roggenbuck, Dirk
author_sort Schmidt, Jonas
collection PubMed
description To study host-virus interactions after SARS coronavirus-2 (SARS-CoV-2) infection, genetic virus characteristics and the ensued humoral immune response were investigated for the first time. Fifty-five SARS-CoV-2-infected patients from the early pandemic phase were followed up including serological testing and whole genome sequencing. Anti-spike and nucleocapsid protein (S/N) IgG and IgM levels were determined by screening ELISA and IgG was further characterized by reactivity to S-subunit 1 (anti-S1), S-subunit 2 (anti-S2) and anti-N. In 55 patients, 90 genetic SARS-CoV-2 changes including 48 non-synonymous single nucleotide variants were identified. Phylogenetic analysis of the sequencing data showed a cluster representing a local outbreak and various family clusters. Anti-S/N and anti-N IgG were detected in 49 patients at an average of 83 days after blood collection. Anti-S/N IgM occurred significantly less frequently than IgG whereas anti-S2 was the least prevalent IgG reactivity (P < 0.05, respectively). Age and overweight were significantly associated with higher anti-S/N and anti-S1 IgG levels while age only with anti-N IgG (multiple regression, P < 0.05, respectively). Anti-S/N IgG/IgM levels, blood group A + , cardiovascular and tumour disease, NSP12 Q444H and ORF3a S177I were independent predictors of clinical characteristics with anti-S/N IgM being associated with the need for hospitalization (multivariate regression, P < 0.05, respectively). Anti-SARS-CoV-2 antibody generation was mainly affected by higher age and overweight in the present cohort. COVID-19 traits were associated with genetic SARS-CoV-2 variants, anti-S/N IgG/IgM levels, blood group A + and concomitant disease. Anti-S/N IgM was the only antibody associated with the need for hospitalization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11357-021-00443-w.
format Online
Article
Text
id pubmed-8408040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84080402021-09-01 Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics Schmidt, Jonas Berghaus, Sandro Blessing, Frithjof Wenzel, Folker Herbeck, Holger Blessing, Josef Schierack, Peter Rödiger, Stefan Roggenbuck, Dirk GeroScience Original Article To study host-virus interactions after SARS coronavirus-2 (SARS-CoV-2) infection, genetic virus characteristics and the ensued humoral immune response were investigated for the first time. Fifty-five SARS-CoV-2-infected patients from the early pandemic phase were followed up including serological testing and whole genome sequencing. Anti-spike and nucleocapsid protein (S/N) IgG and IgM levels were determined by screening ELISA and IgG was further characterized by reactivity to S-subunit 1 (anti-S1), S-subunit 2 (anti-S2) and anti-N. In 55 patients, 90 genetic SARS-CoV-2 changes including 48 non-synonymous single nucleotide variants were identified. Phylogenetic analysis of the sequencing data showed a cluster representing a local outbreak and various family clusters. Anti-S/N and anti-N IgG were detected in 49 patients at an average of 83 days after blood collection. Anti-S/N IgM occurred significantly less frequently than IgG whereas anti-S2 was the least prevalent IgG reactivity (P < 0.05, respectively). Age and overweight were significantly associated with higher anti-S/N and anti-S1 IgG levels while age only with anti-N IgG (multiple regression, P < 0.05, respectively). Anti-S/N IgG/IgM levels, blood group A + , cardiovascular and tumour disease, NSP12 Q444H and ORF3a S177I were independent predictors of clinical characteristics with anti-S/N IgM being associated with the need for hospitalization (multivariate regression, P < 0.05, respectively). Anti-SARS-CoV-2 antibody generation was mainly affected by higher age and overweight in the present cohort. COVID-19 traits were associated with genetic SARS-CoV-2 variants, anti-S/N IgG/IgM levels, blood group A + and concomitant disease. Anti-S/N IgM was the only antibody associated with the need for hospitalization. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11357-021-00443-w. Springer International Publishing 2021-09-01 /pmc/articles/PMC8408040/ /pubmed/34468954 http://dx.doi.org/10.1007/s11357-021-00443-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Schmidt, Jonas
Berghaus, Sandro
Blessing, Frithjof
Wenzel, Folker
Herbeck, Holger
Blessing, Josef
Schierack, Peter
Rödiger, Stefan
Roggenbuck, Dirk
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
title Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
title_full Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
title_fullStr Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
title_full_unstemmed Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
title_short Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort—correlation with disease characteristics
title_sort serological and viral genetic features of patients with covid-19 in a selected german patient cohort—correlation with disease characteristics
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408040/
https://www.ncbi.nlm.nih.gov/pubmed/34468954
http://dx.doi.org/10.1007/s11357-021-00443-w
work_keys_str_mv AT schmidtjonas serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT berghaussandro serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT blessingfrithjof serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT wenzelfolker serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT herbeckholger serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT blessingjosef serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT schierackpeter serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT rodigerstefan serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics
AT roggenbuckdirk serologicalandviralgeneticfeaturesofpatientswithcovid19inaselectedgermanpatientcohortcorrelationwithdiseasecharacteristics